ASTHMAXcel Emergency Department Study
NCT05013073 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2023-09-21
Summary
This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.
Conditions
- Asthma
- Asthma Attack
Interventions
- OTHER
-
ASTHMAXcel ED Application
A mobile application designed to assist patients in asthma symptom recognition, treatment best practices, and trigger identification.
Sponsors & Collaborators
-
Montefiore Medical Center
lead OTHER
Principal Investigators
-
Benjamin W Friedman, MD · Montefiore Medical Center
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2023-02-07
- Completion
- 2023-02-07
Countries
- United States
Study Locations
More Related Trials
-
Emergency Department (ED)-Directed Interventions to Improve Asthma Outcomes
NCT01079000 ·Status: COMPLETED ·Phase: NA
-
Asthma Patient Education in the Emergency Room
NCT00110409 ·Status: COMPLETED ·Phase: NA
-
Educational Video for Improving Follow-up After an Emergency Department Visit for Asthma
NCT00113633 ·Status: COMPLETED ·Phase: NA
-
Telemedicine Enhanced Asthma Management Through the Emergency Department
NCT02752165 ·Status: COMPLETED ·Phase: NA
-
ASTHMAXcel Voice Study
NCT06935084 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics
NCT02270827 ·Status: TERMINATED
-
Imaging Study of the Lungs During an Allergic Asthma Attack
NCT01547286 ·Status: COMPLETED ·Phase: NA
-
Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department
NCT00388739 ·Status: WITHDRAWN ·Phase: NA
-
Determinants Of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth
NCT02013076 ·Status: COMPLETED
-
Community Empowerment to Pilot a Novel Device for Monitoring Rescue Medication Use in Urban Children With Asthma
NCT02517047 ·Status: COMPLETED ·Phase: NA
-
Symptom Clusters in Children With Exacerbation-prone Asthma
NCT04002362 ·Status: COMPLETED ·Phase: PHASE2
-
RCT of a Written Action Plan vs. Usual Care in Children With Acute Asthma
NCT00381355 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
NCT00819637 ·Status: TERMINATED ·Phase: PHASE4
-
Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management
NCT02333630 ·Status: COMPLETED ·Phase: NA
-
Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
NCT00327197 ·Status: TERMINATED ·Phase: PHASE1
-
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
NCT07228052 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
NCT00588406 ·Status: COMPLETED ·Phase: PHASE3
-
Asthma Express: Bridging the Emergency to Primary Care in Underserved Children
NCT01981564 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
NCT05035862 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
NCT01502371 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Pulmozyme to Treat Severe Asthma Episodes
NCT00169962 ·Status: COMPLETED ·Phase: PHASE2
-
Telecommunications System in Asthma
NCT00232557 ·Status: COMPLETED ·Phase: PHASE3
-
Airflow Obstruction and Biomarkers of Airway Inflammation During and Following Acute Exacerbations of Childhood Asthma
NCT01227070 ·Status: COMPLETED
-
Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
NCT01881412 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma
NCT02336425 ·Status: TERMINATED ·Phase: PHASE2